Literature DB >> 17175001

Hepatitis C virus infects T cells and affects interferon-gamma signaling in T cell lines.

Yasuteru Kondo1, Vicky M H Sung, Keigo Machida, Minyi Liu, Michael M C Lai.   

Abstract

It has been reported that hepatitis C virus (HCV) may infect and replicate in human T cells, particularly in perihepatic lymph nodes, but the extent and consequence of T-cell infection in patients is unclear. This study is conducted to characterize the parameters and functional consequences of HCV infection in T lymphocytes. By using a lymphotropic HCV strain, we showed that HCV could infect T cell lines (Molt-4 and Jurkat cells) in vitro. Both positive- and negative-strand HCV RNA were detected for several weeks after infection. Viral proteins could also be detected by immunofluorescence studies. Moreover, infectious HCV particles were produced from Molt-4 cell cultures, and could be used to infect naïve T cell lines. HCV could also infect human primary CD4+ T cells, particularly naïve (CD45RA+CD45RO-) CD4+ cells, in culture. The amounts of STAT-1 and phosphorylated STAT-1 proteins in the infected Molt-4 cells were significantly less than those in uninfected cultures, suggesting the possibility of defect in interferon-gamma signaling. Indeed, T-bet and STAT-1 mRNA levels after interferon-gamma stimulation in infected Molt-4 were suppressed. In conclusion, HCV could infect and transiently replicate in T cells and that HCV replication suppressed the IFN-gamma/STAT-1/T-bet signaling due to the reduction of STAT-1 and inhibition of its activation (phosphorylation).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17175001     DOI: 10.1016/j.virol.2006.11.009

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Occult hepatitis C virus infection and its relevance in clinical practice.

Authors:  Tram Nq Pham; Tomasz I Michalak
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

2.  TBX21 polymorphisms are associated with virus persistence in hepatitis C virus infection patients from a high-risk Chinese population.

Authors:  D Y Zhu; L F Jiang; X Z Deng; W Xiao; J P Pei; B J Li; C J Wang; J H Zhang; Q Zhang; Z X Zhou; W L Ding; X D Xu; M Yue
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-11       Impact factor: 3.267

3.  Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.

Authors:  Elisavet Serti; Polyxeni P Doumba; George Thyphronitis; Panagiota Tsitoura; Konstantina Katsarou; Pelagia Foka; Manousos M Konstandoulakis; John Koskinas; Penelope Mavromara; Urania Georgopoulou
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

4.  Potential Role of Hepatitis C Virus Alternate Reading Frame Protein in Negative Regulation of T-Bet Gene Expression.

Authors:  Dan Yan Zhu; Xiao Zhao Deng; Long Feng Jiang; Wen Xiao; Jia Ping Pei; Bing Jun Li; Chang Jun Wang; Jin Hai Zhang; Qi Zhang; Zhen Xian Zhou; Wei Liang Ding; Xiao Dong Xu; Ming Yue
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

5.  Hepatitis C virus and peripheral blood mononuclear cell reservoirs Patricia Baré.

Authors:  Patricia Baré
Journal:  World J Hepatol       Date:  2009-10-31

6.  Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.

Authors:  Ashley D Frazier; Chun L Zhang; Lei Ni; Cheng J Ma; Ying Zhang; Xiao Y Wu; Antwan N Atia; Zhi Q Yao; Jonathan P Moorman
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

7.  CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.

Authors:  Melissa A Sheiko; Lucy Golden-Mason; Silvia Giugliano; Christine Waasdorp Hurtado; Cara L Mack; Michael R Narkewicz; Hugo R Rosen
Journal:  J Pediatr       Date:  2015-12-30       Impact factor: 4.406

8.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Hepatitis C virus (HCV)-induced immunoglobulin hypermutation reduces the affinity and neutralizing activities of antibodies against HCV envelope protein.

Authors:  Keigo Machida; Yasuteru Kondo; Jeffrey Y Huang; Yung-Chia Chen; Kevin T-H Cheng; Zhenyong Keck; Steven Foung; Jean Dubuisson; Vicky M-H Sung; Michael M C Lai
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.

Authors:  Keigo Machida; Kyoko Tsukiyama-Kohara; Satoshi Sekiguch; Eiji Seike; Shigenobu Tóne; Yukiko Hayashi; Yoshimi Tobita; Yuri Kasama; Masumi Shimizu; Hidemi Takahashi; Chyoji Taya; Hiromichi Yonekawa; Nobuyuki Tanaka; Michinori Kohara
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.